BCL2 and neoplasm: The favorable prognostic value of Bcl-2 positivity was also significant in overall survival (HR = 0.58, 95%-CI: 0.37–0.90; p = 0.015) with the pathologic tumor size, pathologic nodal stage, distant metastasis, and tumor-associated inflammation as the covariates of the model (Table 3).